Seven years after the FDA approved the first tomosynthesis device for breast cancer screening, adoption rates for digital breast tomosynthesis (DBT) remain on an upswing. Earlier this year the agency reported a nearly 30 percent increase of certified mammography facilities offering DBT—aka “3D mammography,” aka “tomo”—over just the past year (from 3,178 facilities in March 2017 to 4,074 in March 2018).

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) have published new breast cancer screening guidelines, once again recommending that all women begin annual screening at age 40.

The Society of Breast Imaging (SBI) is working with the American College of Radiology (ACR) to host its annual Breast Imaging Symposium April 12-15 in Las Vegas.

Jay A. Baker, MD, professor of radiology and chief of the breast imaging division at Duke University Medical Center in Durham, North Carolina, and the vice president of the Society of Breast Imaging (SBI), spoke with Radiology Business about some of the biggest topics affecting breast imaging today.

CHICAGO, Nov. 27, 2017 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today announced positive data from PIONEER, a Phase III pivotal trial of its Imagio™ breast imaging system. The study found that OA/US was more specific than device gray-scale ultrasound alone (US) in differentiating malignant from benign breast lesions and was non-inferior to US with respect to sensitivity.

Shortly before her 40th birthday, a woman visits her primary care physician and is advised she should schedule her first mammogram. The patient is puzzled and says she “read somewhere” that she can wait a few years. The physician has heard this before and kindly convinces the patient to comply with the recommendation. She agrees, schedules the mammogram and receives her results before even leaving the imaging facility. 

While early screening and detection can play an important role in preventing breast cancer, new research from Mayo Clinic shows that some women, particularly minority women, aren’t being screened as often as their white counterparts. 

Multiple patient advocacy groups and healthcare organizations, including the American College of Radiology (ACR) and Society of Breast Imaging (SBI), are asking Congress to extend a federal mandate that requires insurance companies to fully insure annual mammograms for women 40 years old and older.